Shweta R. Motiwala, M.D.
NPI 1942437470ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· San Francisco, CA
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (M.D.) in San Francisco, California, trained at New York University School of Medicine (class of 2009). Their prescriptions cost Medicare Part D more than their services did: $82,758 for 329 claims, against $54,919 paid for services in 2024. Cvrx, Inc. was the largest of 2 companies reporting payments in 2025, $1,337 in all, mostly travel and lodging.
Overview
| NPI | 1942437470 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Jun 11, 2009 |
| Last updated in NPPES | Feb 2, 2024 |
| Certified by provider | Feb 2, 2024 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | C192162 | CA |
| Internal Medicine | 207R00000X | L-240114 | MA |
| Internal Medicine | 207R00000X | C192162 | CA |
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology | 207RA0001X | 250282 | MA |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | 250282 | MA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (CA); Practitioner - Advanced Heart Failure and Transplant Cardiology (MA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 117 |
|---|---|
| Services billed | 676 across 14 procedure codes |
| Paid by Medicare | $54,919 |
Part D prescriptions in 2024
| Prescriptions (claims) | 329 · 664 30-day fills |
|---|---|
| Patients | 72 |
| Total drug cost | $82,758 |
| Generic share | 77% of claims |
Education and affiliations
| Medical school | New York University School of Medicine |
|---|---|
| Graduation year | 2009 |
| Medicare specialty | Advanced Heart Failure And Transplant Cardiology |
| Secondary specialties | Cardiovascular Disease (Cardiology), Internal Medicine |
| Telehealth | Offers telehealth |
Medical groups
- University of California San FranciscoSan Francisco, CA · 1,839 clinicians
- UCSF Medical Group Business ServicesSan Francisco, CA · 1,598 clinicians
- Regents of the University of CaliforniaSan Francisco, CA · 732 clinicians
Hospital affiliation
- UCSF Medical CenterSan Francisco, CA
Industry payments (Open Payments)
- 2025$1,337 · 7 payments from 2 companies
- 2024$165.93 · 1 payment from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Cvrx, Inc. | $1,312 | 6 |
| Abbott Laboratories | $24.81 | 1 |
What the 2025 payments were for
- Travel and Lodging$840.62 · 3 payments
- Food and Beverage$496.43 · 4 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in San Francisco
- 1720377146
- 1861811044
- 1003254186
- 1669420956
- 1699207217
- 1942162144
- 1386873370
- 1184959272
- 1235199340
- 1699113407
- 1184157323
- 1194735019
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in California →